Erratum: Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24. (International Journal of Cancer (2013) 133:11( 2726-2736) DOI: 10.1002/ijc.28289);Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24

International Journal of Cancer

Volumn 133, Issue 11, 2013, Pages 2726-2736

  Bhutia, Sujit K ^a,d   Das, Swadesh K ^a,b   Azab, Belal ^a   Menezes, Mitchell E ^a   Dent, Paul ^a,b,c   Wang, Xiang Yang ^a,b,c   Sarkar, Devanand ^a,b,c   Fisher, Paul B ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

apoptosis; breast cancer; cancer initiating stem cells; MDA 7 IL 24; Wnt signaling

Indexed keywords

ADENOVIRUS VECTOR; BETA CATENIN; INTERLEUKIN 24; LITHIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER STEM CELL; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERLEUKIN 24 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; WNT SIGNALING PATHWAY;

EID: 84884853347     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30058     Document Type: Erratum

References (49)

1. Goldhirsch A, Colleoni M, Domenighetti G, et al. Systemic treatments for women with breast cancer: outcome with relation to screening for the disease. Ann Oncol 2003; 14: 1212-14.
2. Charafe-Jauffret E, Monville F, Ginestier C, et al. Cancer stem cells in breast: current opinion and future challenges. Pathobiology 2008; 75: 75-84.
3. Creighton CJ, Li X, Landis M, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 2009; 106: 13820-5.
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-8.
5. Han JS, Crowe DL,. Tumor initiating cancer stem cells from human breast cancer cell lines. Int J Oncol 2009; 34: 1449-53.
6. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65: 5506-11.
7. Liu S, Dontu G, Wicha MS,. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 2005; 7: 86-95.
8. Clevers H,. Wnt/β-catenin signaling in development and disease. Cell 2006; 127: 469-80.
9. Liu C, Li Y, Semenov M, et al. Control of β-catenin phosphorylation/ degradation by a dual-kinase mechanism. Cell 2002; 108: 837-47.
10. Korkaya H, Paulson A, Charafe-Jauffret E, et al. Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling. PLoS Biol 2009; 7: e1000121.
11. Kruyt FA, Schuringa JJ,. Apoptosis and cancer stem cells: implications for apoptosis targeted therapy. Biochem Pharmacol 2010; 80: 423-30.
12. Huang M, Li Y, Wu G, et al. Whole genome expression profiling reveals a significant role for the cell junction and apoptosis pathways in breast cancer stem cells. Mol Biotechnol 2010; 45: 39-48.
13. Jiang H, Lin JJ, Su ZZ, et al. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11: 2477-86.
14. Dash R, Bhutia SK, Azab B, et al. mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine Growth Factor Rev 2010; 2: 381-91.
15. Pestka S, Krause CD, Sarkar D, et al. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22: 929-79.
16. Fisher PB, Gopalkrishnan RV, Chada S, et al. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol Ther 2003; 2: S23-S37.
17. Fisher PB,. Is mda-7/IL-24 a "magic bullet" for cancer? Cancer Res 2005; 65: 10128-38.
18. Cunningham CC, Chada S, Merritt JA, et al. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 2005; 11: 149-59.
19. Tong AW, Nemunaitis J, Su D, et al. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 2005; 11: 160-72.
20. Lebedeva IV, Emdad L, Su ZZ, et al. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience. Int J Oncol 2007; 31: 985-1007.
21. Sarkar D, Lebedeva IV, Gupta P, et al. Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy? Expert Opin Biol Ther 2007; 7: 577-86.
22. Ramesh R, Mhashilkar AM, Tanaka F, et al. Melanoma differentiation- associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res 2003; 63: 5105-13.
23. Miyahara R, Banerjee S, Kawano K, et al. Melanoma differentiation associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model. Cancer Gene Ther 2006; 13: 753-61.
24. Su ZZ, Lebedeva IV, Sarkar D, et al. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene 2006; 25: 2339-48.
25. Yacoub A, Hamed H, Emdad L, et al. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. Cancer Biol Ther 2008; 7: 917-33.
26. Sauane M, Su ZZ, Gupta P, et al. Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc Natl Acad Sci USA 2008; 105: 9763-8.
27. Su Z, Emdad L, Sauane M, et al. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene 2005; 24: 7552-66.
28. Gupta P, Walter MR, Su ZZ, et al. BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res 2006; 66: 8182-91.
29. Su ZZ, Madireddi MT, Lin JJ, et al. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci USA 1998; 95: 14400-5.
30. Mc, Kenzie T, Liu Y, Fanale M, et al. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery 2004; 136: 437-42.
31. Suh YJ, Chada S, McKenzie T, et al. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells. Surgery 2005; 138: 422-30.
32. Bocangel D, Zheng M, Mhashilkar A, et al. Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells. Cancer Gene Ther 2006; 13: 958-68.
33. Sarkar D, Su ZZ, Vozhilla N, et al. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc Natl Acad Sci USA 2005; 102: 14034-9.
34. Mhashilkar AM, Stewart AL, Sieger K, et al. MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol Ther 2003; 8: 207-19.
35. Chada S, Bocangel D, Ramesh R, et al. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer. Mol Ther 2005; 11: 724-33.
36. Li Y, Zhang T, Korkaya H, et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res 2010; 16: 2580-90.
37. Harrison H, Farnie G, Howell SJ, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 2010; 70: 709-18.
38. Hedgepeth CM, Conrad LJ, Zhang J, et al. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 1997; 185: 82-91.
39. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11.
40. Kakarala M, Wicha MS,. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 2008; 26: 2813-20.
41. Sakariassen PO, Immervoll H, Chekenya M,. Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 2007; 9: 882-92.
42. Dean M, Fojo T, Bates S,. Tumor stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275-84.
43. Chuthapisith S, Eremin J, El-Sheemey M, et al. Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol 2010; 19: 27-32.
44. McDermott SP, Wicha MS,. Targeting breast cancer stem cells. Mol Oncol 2010; 4: 404-19.
45. Rahmani M, Mayo M, Dash R, et al. MDA-7/IL-24 potently induces apoptosis in human myeloid leukemia cells through a process regulated by ER stress. Mol Pharmacol 2010; 78: 1096-104.
46. You L, He B, Xu Z, et al. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res 2004; 64: 5385-9.
47. Kawasaki BT, Hurt EM, Mistree T, et al. Targeting cancer stem cells with phytochemicals. Mol Interv 2008; 8: 174-84.
48. Zolochevska O, Yu G, Gimble JM, et al. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth. Stem Cells Dev 2012; 21: 1112-23.
49. Hingtgen S, Kasmieh R, Elbayly E, et al. A first generation multi-functional cytokine for simultaneous optical tracking and tumor therapy. PLoS One 2012; 7: e40234.